Enfermedades Sistémicas de Base Autoinmune

Alvaro-Gracia, JM; Garcia-Llorente, JF; Valderrama, M; Gomez, S; Montoro, M.

Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review

Rheumatology and Therapy. 2021; 8(1): 17-40 Nº de citas: 27 [doi:10.1007/s40744-020-00258-9]

Collada, JM; Castrejon, I; Perez, M; Nieto-Gonzalez, JC; Gonzalez, T; Rivera, J; Gonzalez, C; Alvaro-Gracia, JM.

Clinical impact of musculoskeletal ultrasound on rheumatoid arthritis in routine care

International Journal of Rheumatic Diseases. 2021; 24(3): 341-346 Nº de citas: 4 [doi:10.1111/1756-185X.14040]

Masmitja, JG; Fernandez, CMG; Castro, SG; Laserna, FJR.

Efficacy of Tofacitinib in the Treatment of Psoriatic Arthritis: A Systematic Review

ADVANCES IN THERAPY. 2021; 38(2): 868-884 Nº de citas: 10 [doi:10.1007/s12325-020-01585-7]

Fernández Castro M; López-Pintor RM; Serrano J; Ramírez L; Sanz M; Andreu JL; Muñoz Fernández S.

Protocolised odontological assessment of patients with primary Sjögren's syndrome.

Reumatologia Clinica. 2021; 17(1): 25-31 Nº de citas: 7 [doi:10.1016/j.reuma.2018.12.005]

Rivera, J; Castrejon, I; Vallejo-Slocker, L; Offenbacher, M; Molina-Collada, J; Trives, L; Lopez, K; Caballero, L; Hirsch, JK; Toussaint, L; Nieto, JC; Alvaro-Gracia, JM; Vallejo, MA.

Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort study

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3): 78-81 Nº de citas: 2

Collada, JM; Trives, L; Castrejon, I.

The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases

OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS. 2021; 13: 191-200 Nº de citas: 3 [doi:10.2147/OARRR.S276980]

Morla, RM; Li, TF; Castrejon, I; Luta, G; Pincus, T.

Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care

ARTHRITIS CARE & RESEARCH. 2021; 73(1): 120-129 Nº de citas: 12 [doi:10.1002/acr.24467]

Pablos, JL; Galindo, M; Carmona, L; Lled, A; Retuerto, M; Blanco, R; Gonzalez-Gay, MA; Martinez-Lopez, D; Castrejon, I; Alvaro-Gracia, JM; Fernandez, DF; Mera-Varela, A; Manrique-Arija, S; Vazquez, NM; Fernandez-Nebro, A.

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

ANNALS OF THE RHEUMATIC DISEASES. 2020; 79(12): 1544-1549 Nº de citas: 193 [doi:10.1136/annrheumdis-2020-218296]

de Toro, J; Gonzalez, CM; Cea-Calvo, L; Arteaga, MJ; Fernandez, S; Carmona, L; Oton, T.

Patients' perceptions on shared decision making during prescription of subcutaneous biological drug treatments for inflammatory arthritis: The RHEU-LIFE survey

Musculoskeletal care. 2020; 18(4): 568-574 Nº de citas: 5 [doi:10.1002/msc.1499]

Burmester, GR; Alvaro-Gracia, JM; Betteridge, N; Alen, JC; Combe, B; Durez, P; Fautrel, B; Ferreira, RJO; Gabay, C; Iagnocco, A; Montecucco, C; Ostergaard, M; Ramiro, S; Rubbert-Roth, A; Stamm, T; Szekanecz, Z; Taylor, PC; van de Laar, M.

Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2020; 38(6): 1056-1067 Nº de citas: 3

Manzano, EM; Fernandez-Bello, I; Sanz, RJ; Marhuenda, AR; Lopez-Longo, FJ; Acuna, P; Roman, MTA; Yuste, VJ; Butta, NV.

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies

Journal of Clinical Medicine. 2020; 9(10): Nº de citas: 9 [doi:10.3390/jcm9103297]

Arora, S; Isenberg, DA; Castrejon, I.

Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage

ARTHRITIS CARE & RESEARCH. 2020; 72: 27-46 Nº de citas: 45 [doi:10.1002/acr.24221]

Riancho-Zarrabeitia, L; Martinez-Taboada, V; Rua-Figueroa, I; Alonso, F; Galindo-Izquierdo, M; Ovalles, J; Olive-Marques, A; Fernandez-Nebro, A; Calvo-Alen, J; Menor-Almagro, R; Tomero-Muriel, E; Uriarte-Isacelaya, E; Botenau, A; Andres, M; Freire-Gonzalez, M; Soler, GS; Ruiz-Lucea, E; Ibanez-Barcelo, M; Castellvi, I; Galisteo, C; Vila, VQ; Raya, E; Narvaez-Garcia, J; Exposito, L; Hernandez-Beriain, JA; Horcada, L; Aurrecoechea, E; Pego-Reigosa, JM.

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

LUPUS. 2020; 29(12): 1556-1565 Nº de citas: 33 [doi:10.1177/0961203320950477]

Montero, F; Martinez-Barrio, J; Serrano-Benavente, B; Gonzalez, T; Rivera, J; Collada, JM; Castrejon, I; Alvaro-Gracia, J.

Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes

RHEUMATOLOGY INTERNATIONAL. 2020; 40(10): 1593-1598 Nº de citas: 86 [doi:10.1007/s00296-020-04676-4]

Pablos, JL; Abasolo, L; Alvaro-Gracia, JM; Blanco, FJ; Blanco, R; Castrejon, I; Fernandez-Fernandez, D; Fernandez-Gutierrez, B; Galindo-Izquierdo, M; Gonzalez-Gay, MA; Manrique-Arija, S; Vazquez, NM; Varela, AM; Retuerto, M; Seijas-Lopez, A.

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

ANNALS OF THE RHEUMATIC DISEASES. 2020; 79(9): 1170-1173 Nº de citas: 115 [doi:10.1136/annrheumdis-2020-217763]

Hirsch, JK; Toussaint, L; Offenbacher, M; Kohls, N; Hanshans, C; Vallejo, M; Rivera, J; Sirois, F; Untner, J; Holzl, B; Gaisberger, M; Ndosi, M.

Educational needs of patients with rheumatic and musculoskeletal diseases attending a large health facility in Austria

Musculoskeletal care. 2020; 18(3): 391-396 Nº de citas: 7 [doi:10.1002/msc.1474]

Navarro-Compan, V; Oton, T; Loza, E; Almodovar, R; Ariza-Ariza, R; Bautista-Molano, W; Burgos-Vargas, R; Collantes-Estevez, E; de Miguel, E; Gonzalez-Fernandez, C; Gratacos, J; Ibanez, S; Juanola, X; Maldonado-Cocco, J; Molto, A; Mulero, J; Pacheco-Tena, C; Ramos-Remus, C; Sanz-Sanz, J; Valle-Onate, R; Zarco, P; Marzo-Ortega, H.

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis

Reumatologia Clinica. 2020; 16(5): 333-338 Nº de citas: 2 [doi:10.1016/j.reuma.2018.07.014]

Torrente-Segarra, V; Salman-Monte, TC; Rua-Figueroa, I; del Campo, V; Lopez-Longo, FJ; Galindo-Izquierdo, M; Calvo-Alen, J; Olive-Marques, A; Mourino-Rodriguez, C; Horcada, L; Bohorquez, C; Montilla, C; Salgado, E; Diez-Alvarez, E; Blanco, R; Andreu, JL; Fernandez-Berrizbeitia, O; Exposito, L; Gantes, M; Hernandez-Cruz, B; Pecondon-Espanol, A; Lozano-Rivas, N; Bonilla, G; Iglesias, AL; Rubio-Munoz, P; Ovalles, J; Tomero, E; Boteanu, A; Narvaez, J; Freire, M; Vela, P; Quevedo-Vila, V; Mas, AJ; Munoz-Fernandez, S; Raya, E; Moreno, M; Velloso-Feijoo, ML; Soler, G; Vazquez-Rodriguez, TR; Pego-Reigosa, JM.

Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER)

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2020; 50(4): 657-662 Nº de citas: 7 [doi:10.1016/j.semarthrit.2020.05.016]